PTGR1 and clear cell renal carcinoma: Considering these criteria 36 of the total number of 389 TCGA cases (~ 9%) indicated the presence of both NER deficiency and significant PTGR1 expression levels thus defining the proportion of clear cell renal carcinoma cases that may respond to irofulven therapy (Fig. 5B).